Images List Premium Download Classic

Vascular Diseases

Vascular Diseases-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions
The Regents Of The University Of California
January 11, 2018 - N°20180010148

In alternative embodiments, the invention provides methods for treating, ameliorating or protecting (preventing) an individual or a patient against a disease, an infection or a condition responsive to an increased paracrine polypeptide level in vivo comprising: providing a paracrine polypeptide-encoding nucleic acid or gene operatively linked to a transcriptional regulatory sequence; or an expression vehicle, a vector, a recombinant virus, ...
Method of enhancing mir-185 expression to reduce low density lipoprotein/cholesterol accumulation in a cell
Medical Diagnostic Laboratories, Llc
January 11, 2018 - N°20180010127

The present invention provides a method of quantifying mir-185 as a potential biomarker in lipid disorder or cardiovascular diseases in human. The present invention also provides a method of modulating mir-185 in regulating ldl and cholesterol metabolism in cells. The present invention has therapeutic potential in the treatment of cholesterol/ldl related cardiovascular diseases in humans.
Novel diagnostic and therapeutic target in inflammatory and/or cardiovascular diseases
University Of Zurich
January 11, 2018 - N°20180009907

Methods for diagnosing inflammatory and/or cardiovascular diseases by assaying for fibroblast activation protein (fap) expression in a body fluid is provided as well as therapeutic means based thereon.
Vascular Diseases Patent Pack
Download 120+ patent application PDFs
Vascular Diseases Patent Applications
Download 120+ Vascular Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 120+ full patent PDF documents of Vascular Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Inhibitors of the renal outer medullary potassium channel
Merck Sharp & Dohme Corp.
January 11, 2018 - N°20180009807

The present invention provides compounds of formula i (i) and the pharmaceutically acceptable salts thereof, which are inhibitors of the romk (kir1. 1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive ...
Tetrahydroquinoline derivatives and their use as epac inhibitors
Universite D'orleans
January 11, 2018 - N°20180009757

The invention relates to tetrahydroquinoline derivatives and their use in the treatment and/or the prevention of a disease wherein the epac protein is involved, such as inflammation, cancer, vascular diseases, kidney diseases, cognitive disorders and cardiac diseases.
Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and hmg coa ...
Dezima Pharma B.v.
January 04, 2018 - N°20180000818

The present invention relates to a pharmaceutical composition and a therapeutic combination comprising a novel cholesteryl ester transfer protein (cetp) inhibitor and a hmg coa reductase inhibitor, which may be used in the treatment of subjects suffering from or having an increased risk for cardiovascular diseases, in particular hyperlipidemia or mixed dyslipidemia.
Vascular Diseases Patent Pack
Download 120+ patent application PDFs
Vascular Diseases Patent Applications
Download 120+ Vascular Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 120+ full patent PDF documents of Vascular Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2)
Siemens Healthcare Diagnostics Inc.
December 28, 2017 - N°20170368171

The invention provides human adipor2 which is associated with the cardiovascular diseases, dermatological diseases, gastroenterological diseases, cancer, hematological diseases, respiratory diseases, inflammation, neurological diseases, urological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular diseases, dermatological diseases, gastroenterological diseases, cancer, hematological diseases, respiratory diseases, inflammation, neurological diseases, urological diseases. The ...
Biomarker for diagnosing vascular diseases and the uses thereof
Wonmedical Corp.
December 21, 2017 - N°20170363640

Provided are a composition for diagnosing vascular disease including an agent measuring a level of interleukin 12 receptor β2 protein in the blood, and a kit for diagnosing vascular disease including the same. Further, provided is a method for diagnosing vascular disease, the method including the step of measuring a level of interleukin 12 receptor β2 protein in a blood ...
Adenylyl cyclase inhibitors, pharmaceutical compositions and method of use thereof
Wonmedical Corp.
December 21, 2017 - N°20170362235

Wherein x, l, r1, r2, r5 are those defined herein. Compounds of the present invention are useful to treat cardiovascular diseases. The present invention also relates to a method of preventing heart failure by administering an effective amount of compound according to the invention following vascular injury and reperfusion therapy.
Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
Wonmedical Corp.
December 21, 2017 - N°20170362227

The present invention relates to compounds inhibiting autotaxin (npp2 or enpp2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, and/or abnormal angiogenesis associated diseases by administering ...
Neuregulin based methods and compositions for treating cardiovascular diseases
Zensun (shanghai) Science & Technology, Co., Ltd.
December 21, 2017 - N°20170360889

The present invention relates to compositions and methods for preventing, treating or delaying various cardiovascular diseases or disorders in mammals, particularly in humans. More particularly, the present invention provides for compositions and methods for preventing, treating or delaying various cardiovascular diseases or disorders using, inter alia, a neuregulin protein, or a functional fragment thereof, or a nucleic acid encoding a ...
Compositions and methods for the prevention and treatment of cardiovascular diseases
Reven Pharmaceuticals Inc.
December 21, 2017 - N°20170360696

Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided.
Chinese medicinal composition for preventing or treating cardiovascular and cerebrovascular diseases or dementia, and preparation ...
Shineway Pharmaceutical Group Ltd.
December 14, 2017 - N°20170354700

Disclosed are a chinese medicinal composition for preventing or treating cardiovascular and cerebrovascular diseases and/or dementia, and a preparation method and use thereof. The composition is prepared from the following medical raw materials in parts by weight: 1 part of ginseng, 0. 8-1. 5 parts of ginkgo leaf and 0. 018-0. 030 part of stigma croci.
Vascular Diseases Patent Pack
Download 120+ patent application PDFs
Vascular Diseases Patent Applications
Download 120+ Vascular Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 120+ full patent PDF documents of Vascular Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
The Johns Hopkins University
December 07, 2017 - N°20170348307

Methods are provided herein for selectively killing senescent cells and for treating senescence-associated diseases and disorders by administering a senolytic agent. Senescence-associated diseases and disorders treatable by the methods using the senolytic agents described herein include cardiovascular diseases and disorders associated with or caused by arteriosclerosis, such as atherosclerosis; idiopathic pulmonary fibrosis; chronic obstructive pulmonary disease; osteoarthritis; senescence-associated ophthalmic diseases ...
Products for the delivery of therapeutic/diagnostic compounds to the heart
Istituto Nazionale Assicurazione Contro Gli Infortuni Sul Lavoro
December 07, 2017 - N°20170348245

The invention relates to a process for the preparation of a product comprising one or more nanoparticles of calcium phosphate (cap-np) with negative surface charge having a ζ-potential in the range from −41. 0 mv to −27. 0 mv comprising the steps of: a) maintaining a mixture having a ph in the range from 7 to 10 and comprising an aqueous solution ...
Vascular treatment evaluation system, and method therefor
Ebm Corporation
December 07, 2017 - N°20170347966

Provided is a system for supporting the treatment of vascular diseases by performing a blood flow simulation based on a medical image, the system comprising: an input unit that reads the medical image, fluid properties and boundary conditions from a data storage unit; a blood flow analysis execution unit that obtains a pressure field and a flow velocity field based ...
Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia ...
Althera Laboratories Ltd
November 30, 2017 - N°20170340569

The present invention is an orally consumed fixed combination formulation of both rosuvastatin and ezetimibe in one tablet that is expected to have the same area under curve as two active ingredients taken together individually orally, and pharmaceutically acceptable additives suitable for the preparation. In preferred embodiments of this invention, the rosuvastatin is in the form of rosuvastatin calcium and ...
Methods and kits for treating cardiovascular diseases
Rappaport Family Institute For Research In The Medical Sciences
November 23, 2017 - N°20170336420

The present invention is directed to methods and compositions of treating cardiovascular disease or disorder in a subject in need thereof, comprising steps of determining and identifying the haptoglobin phenotype of the subject and thereby selecting the course of treatment with an agent capable of raising hdl.
Mixed disulfide conjugates of thienopyridine compounds and uses thereof
The Regents Of The University Of Michigan
November 23, 2017 - N°20170334853

This invention is in the field of medicinal chemistry. In particular, the invention relates to mixed disulfide conjugates of thienopyridine compounds, and their use as therapeutics for the treatment, amelioration, and prevention of cardiovascular diseases.
Omefibrates for treating dyslipidemia and cardiovascular disease
Jiva Pharma, Inc.
November 16, 2017 - N°20170327455

The present invention relates to the fibric acid derivatives of omega-3 fatty acids and their use in treating type2 diabetes, obesity, hypertriglyceridemia, cardiovascular diseases, metabolic syndrome, cancer, alzheimer's disease; and their use for modulating activity of peroxisome proliferator-activated receptors (ppars).
Amide-substituted pyridinyltriazole derivatives and uses thereof
Bayer Pharma Aktiengesellschaft
November 09, 2017 - N°20170320854

The present invention relates to novel 5-(carboxamide)-1-pyridinyl-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.
Loading